down arrow

Strides Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE939A01011
  • NSEID: STAR
  • BSEID: 532531
INR
607.45
24.75 (4.25%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 2.17 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Rs cr
Consolidate Half Yearly Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
2,288.62
1,929.42
1,837.17
1,409.84
1,575.36
1,400.89
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,288.62
1,929.42
1,837.17
1,409.84
1,575.36
1,400.89
Raw Material Cost
813.06
612.15
865.38
604.16
598.23
567.15
Purchase of Finished goods
134.77
120.14
71.62
144.80
106.01
71.77
(Increase) / Decrease In Stocks
-29.47
70.75
-78.31
-75.22
-93.53
-24.17
Employee Cost
431.58
367.46
375.35
309.71
268.10
206.83
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.00
0.00
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
485.88
439.20
444.85
490.19
379.56
310.72
Total Expenditure (Excl Depreciation)
1,835.83
1,609.70
1,678.89
1,473.64
1,258.36
1,132.30
Operating Profit (PBDIT) excl Other Income
452.79
319.72
158.28
-63.80
317.00
268.59
Other Income
41.13
44.49
37.01
35.74
25.18
23.24
Operating Profit (PBDIT)
493.92
364.21
195.29
-28.06
342.18
291.83
Interest
162.54
155.01
122.18
85.01
73.78
75.76
Exceptional Items
-7.61
-170.91
-51.25
-151.45
58.05
76.79
Gross Profit (PBDT)
323.77
38.29
21.86
-264.52
326.45
292.86
Depreciation
99.12
119.70
122.10
111.44
101.92
84.89
Profit Before Tax
224.65
-81.40
-100.25
-375.96
224.52
207.97
Tax
38.06
2.24
-66.48
-42.30
9.39
10.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
186.58
-83.64
-33.77
-333.65
215.14
197.47
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
18.57
0.00
14.77
-13.59
Net Profit
186.58
-83.64
-15.20
-333.65
229.91
183.88
Share in Profit of Associates
-24.61
-75.18
-101.23
-42.90
-51.08
-39.06
Minority Interest
1.46
20.36
3.36
8.79
5.68
1.60
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
163.43
-138.46
-113.07
-367.76
184.51
146.42
Equity Capital
91.96
90.33
90.29
89.78
89.63
89.55
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
2,315.81
0.00
0.00
Earnings per share (EPS)
17.77
-15.33
-12.52
-40.96
20.59
16.35
Diluted Earnings per share
17.75
-15.33
-12.58
-40.99
20.58
16.35
Operating Profit Margin (Excl OI)
19.78%
16.57%
8.62%
-4.53%
20.12%
19.17%
Gross Profit Margin
14.15%
1.98%
1.19%
-18.76%
20.72%
20.91%
PAT Margin
7.08%
-8.23%
-7.35%
-26.71%
10.41%
11.31%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2024 is 18.62% vs 5.02% in Sep 2023

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2024 is 218.03% vs -22.46% in Sep 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2024 is 41.62% vs 102.00% in Sep 2023

stock-summary

Interest

Growth in half year ended Sep 2024 is 4.86% vs 26.87% in Sep 2023

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2024 has improved from Sep 2023

Compare Half Yearly Results Of Strides Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
2,288.62
5,969.93
-3,681.31
-61.66%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,288.62
5,969.93
-3,681.31
-61.66%
Raw Material Cost
813.06
934.97
-121.91
-13.04%
Purchase of Finished goods
134.77
857.27
-722.50
-84.28%
(Increase) / Decrease In Stocks
-29.47
-104.82
75.35
71.89%
Employee Cost
431.58
1,280.21
-848.63
-66.29%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
485.88
1,470.50
-984.62
-66.96%
Total Expenditure (Excl Depreciation)
1,835.83
4,438.13
-2,602.30
-58.64%
Operating Profit (PBDIT) excl Other Income
452.79
1,531.80
-1,079.01
-70.44%
Other Income
41.13
210.03
-168.90
-80.42%
Operating Profit (PBDIT)
493.92
1,741.83
-1,247.91
-71.64%
Interest
162.54
18.01
144.53
802.50%
Exceptional Items
-7.61
0.00
-7.61
Gross Profit (PBDT)
323.77
1,723.82
-1,400.05
-81.22%
Depreciation
99.12
213.36
-114.24
-53.54%
Profit Before Tax
224.65
1,510.46
-1,285.81
-85.13%
Tax
38.06
314.99
-276.93
-87.92%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
186.58
1,195.47
-1,008.89
-84.39%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
186.58
1,195.47
-1,008.89
-84.39%
Share in Profit of Associates
-24.61
6.48
-31.09
-479.78%
Minority Interest
1.46
-11.99
13.45
112.18%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
163.43
1,189.96
-1,026.53
-86.27%
Equity Capital
91.96
40.06
51.90
129.56%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
17.77
29.70
-11.93
-40.17%
Diluted Earnings per share
17.75
29.65
-11.90
-40.13%
Operating Profit Margin (Excl OI)
19.78%
25.66%
0.00
-5.88%
Gross Profit Margin
14.15%
28.88%
0.00
-14.73%
PAT Margin
7.08%
20.13%
0.00
-13.05%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 2,288.62 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 18.62% vs 5.02% in Sep 2023

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 163.43 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 218.03% vs -22.46% in Sep 2023

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 452.79 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 41.62% vs 102.00% in Sep 2023

Half Yearly - Interest
Interest 162.54 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 4.86% vs 26.87% in Sep 2023

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.78%
in Sep 2024

Figures in Rs %
stock-summary

Growth in half year ended Sep 2024 has improved from Sep 2023